NCT03372278View on ClinicalTrials.gov

PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2028

Conditions
Rheumatoid Arthritis With Adequate Bone QualityInflammatory ArthritisOsteoarthritis, HipAvascular NecrosisPost-traumatic; ArthrosisCongenital Hip Dysplasia
Trial Locations (8)

Unknown

The Mater Hospital, Concord Hospital, Sydney

UZ Leuven, Pellenberg

Center Maisonneuve-Rosemont Hospital, Montreal

Jokilaakson terveys oy, Jämsä

Centre Hospitalier de Perpignan, Perpignan

Reinier de Graaf Groep, Delft

Hospital Son Llatzer, Palma de Mallorca

Royal Liverpool and Broadgreen University Teaching Hospitals, Liverpool

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY